Tag: BA.2.75 fusogenicity
WHO: BA.2.75 has more efficient replication in lung cells, fusogenicity, pathogenicity
WHO: “Preliminary laboratory-based studies indicate a relative growth advantage of BA.2.75 as compared to BA.2 and BA.5. More...
Preprint: Potential risk of BA.2.75 to global health is greater than that of BA.5
BA.2.75 spike exhibited a profound higher affinity to human ACE2 than BA.2 and BA.5 spikes. More...